| scholarly article | Q13442814 |
| P50 | author | Magdalena Plebanski | Q89637130 |
| P2093 | author name string | Kirsty Wilson | |
| Stephanie Day | |||
| Martina Fuchsberger | |||
| Sue D Xiang | |||
| P2860 | cites work | Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy. | Q30377799 |
| Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay | Q33903838 | ||
| CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. | Q33928441 | ||
| Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses | Q33989624 | ||
| Unmet needs in modern vaccinology: adjuvants to improve the immune response | Q34131456 | ||
| TLR-based immune adjuvants. | Q34400322 | ||
| Pathogen recognition and development of particulate vaccines: does size matter? | Q36602254 | ||
| Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. | Q36858877 | ||
| Biodegradable polymeric nanoparticles based drug delivery systems | Q37603750 | ||
| Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response | Q38334354 | ||
| Synthesis and immunological evaluation of self-assembling and self-adjuvanting tricomponent glycopeptide cancer-vaccine candidates | Q39254744 | ||
| Antigen-containing liposomes engrafted with flagellin-related peptides are effective vaccines that can induce potent antitumor immunity and immunotherapeutic effect | Q39683136 | ||
| The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells | Q39732901 | ||
| AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity | Q39782280 | ||
| Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide | Q43094784 | ||
| The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles | Q44467598 | ||
| Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus | Q45407586 | ||
| Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection | Q47182882 | ||
| Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors | Q47409832 | ||
| Targeting nanosystems to human DCs via Fc receptor as an effective strategy to deliver antigen for immunotherapy. | Q50691543 | ||
| Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. | Q51615861 | ||
| ISCOMs: an adjuvant with multiple functions | Q59157581 | ||
| Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions | Q59382820 | ||
| Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific tumour challenge in mice | Q80973779 | ||
| Systemic immune responses in sheep, induced by a novel nano-bead adjuvant | Q81305089 | ||
| Characterization of the role of CD8+T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers | Q81305997 | ||
| Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine | Q83047972 | ||
| P433 | issue | 3 | |
| P921 | main subject | nanoparticle | Q61231 |
| inflammation | Q101991 | ||
| P304 | page(s) | 232-241 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Methods | Q6823859 |
| P1476 | title | Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers. | |
| P478 | volume | 60 |
| Q38913324 | A Model to Study the Impact of Polymorphism Driven Liver-Stage Immune Evasion by Malaria Parasites, to Help Design Effective Cross-Reactive Vaccines |
| Q36409524 | A Nanoparticle Based Sp17 Peptide Vaccine Exposes New Immuno-Dominant and Species Cross-reactive B Cell Epitopes |
| Q64086749 | A Synthetic Nanoparticle Based Vaccine Approach Targeting MSP4/5 Is Immunogenic and Induces Moderate Protection Against Murine Blood-Stage Malaria |
| Q38944133 | A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens |
| Q35826747 | Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators |
| Q37539243 | Co-Administration of Lipid Nanoparticles and Sub-Unit Vaccine Antigens Is Required for Increase in Antigen-Specific Immune Responses in Mice |
| Q33875615 | Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy |
| Q60938378 | Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8 T Cell Responses |
| Q36154772 | Harnessing nanoparticles for immune modulation |
| Q38910964 | Mitochondria and neurodegenerative diseases: the promising role of nanotechnology in targeted drug delivery |
| Q43135615 | Montanide, Poly I:C and nanoparticle based vaccines promote differential suppressor and effector cell expansion: a study of induction of CD8 T cells to a minimal Plasmodium berghei epitope |
| Q37279161 | Nanoparticle-based vaccine delivery for cancer immunotherapy |
| Q37731681 | Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment |
| Q41554436 | Nanoparticles modify dendritic cell homeostasis and induce non-specific effects on immunity to malaria |
| Q38243119 | Oral delivery of nanoparticle-based vaccines. |
| Q38148951 | Recent advances in surface chemistry strategies for the fabrication of functional iron oxide based magnetic nanoparticles |
| Q47663181 | Synthetic Nanoparticles That Promote Tumor Necrosis Factor Receptor 2 Expressing Regulatory T Cells in the Lung and Resistance to Allergic Airways Inflammation. |
Search more.